# EDGAR Filing Document

**Accession Number:** 0001433607
**File Stem:** 0001493152-26-018952
**Filing Date:** 2026-4
**Character Count:** 8173
**Document Hash:** 3904adea8abed3ef4ad31c71e7f59d63
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-018952.hdr.sgml**: 20260424

**ACCESSION NUMBER**: 0001493152-26-018952

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260424

**DATE AS OF CHANGE**: 20260424

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** InspireMD, Inc.
- **CENTRAL INDEX KEY:** 0001433607
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 262123838
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-86184
- **FILM NUMBER:** 26895475

**BUSINESS ADDRESS:**
- **STREET 1:** 6303 WATERFORD DISTRICT DRIVE
- **STREET 2:** SUITE 215
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33126
- **BUSINESS PHONE:** (888) 776-6804

**MAIL ADDRESS:**
- **STREET 1:** 6303 WATERFORD DISTRICT DRIVE
- **STREET 2:** SUITE 215
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33126

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Saguaro Resources, Inc.
- **DATE OF NAME CHANGE:** 20080428
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Slosman Marvin
- **CENTRAL INDEX KEY:** 0001796908

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **STREET 1:** 4 MENORAT HAMAOR ST.
- **STREET 2:** C/O INSPIREMD, INC.
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6744832

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**InspireMD, Inc.**

*(Name of Issuer)*

**Common Stock, $0.0001 par value per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Marvin Slosman**<br>6303 Waterford District Drive, Suite 215<br>Miami FL 33126<br>(888) 776-6804

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**01/22/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Marvin Slosman** | Name of reporting person<br>**Marvin Slosman** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**2556760.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**2556760.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2556760.00** | Aggregate amount beneficially owned by each reporting person<br>**2556760.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.18%** | Percent of class represented by amount in Row (11)<br>**5.18%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** Consists of (i) 16,722 shares of common stock, par value $0.0001 per share (the "Shares") of InspireMD, Inc. (the "Issuer"), (ii) 12,159 restricted stock units granted outside the Issuer's equity incentive plans that are currently exercisable or exercisable within 60 days of the date hereof, (iii) 78,352 restricted stock units granted under the InspireMD, Inc. Long-Term Incentive Plan that are currently exercisable or exercisable within 60 days of the date hereof, (iv) 1,753,522 restricted stock units granted under the InspireMD Inc. 2021 Equity Compensation Plan (the "2021 Equity Incentive Plan") that are currently exercisable or exercisable within 60 days of the date hereof, and (v) 696,005 Shares issuable upon exercise of options granted under the 2021 Equity Incentive Plan that are currently exercisable or exercisable within 60 days of the date hereof. Based upon 46,838,962 Shares issued and outstanding as of the date hereof, which amount was provided to the Reporting Person by the Issuer. Does not include (i) 241,792 Shares issuable upon exercise of options granted under the 2021 Equity Incentive Plan that vest in more than 60 days of the date hereof and (ii) 1,674,903 restricted stock units granted under the 2021 Equity Incentive Plan that vest in more than 60 days of the date hereof.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.0001 par value per share

**(b) Name of Issuer:**
InspireMD, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
6303 Waterford District Drive, Suite 215, Miami, FL, 33126

**Item 4. Purpose of Transaction**

Item 3 above is hereby incorporated into this Item 4 by reference. The Reporting Person serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

As of the date hereof, the Reporting Person in his individual capacity does not have any present plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j) of Item 4 to Schedule 13D. The Reporting Person may, at any time and from time to time, (i) review or reconsider his position in the Issuer or change his purpose or formulate plans or proposals with respect thereto or (ii) propose or consider one or more of the actions described in clauses (a) through (j) of Item 4 to Schedule 13D.

From time to time, the Reporting Person may also acquire beneficial ownership of additional Shares or other securities of the Issuer as compensation from the Issuer, by purchase or otherwise, including, including, but not limited to, awards of restricted Shares, options to purchase Shares, and restricted stock units for Shares, or dispose of some or all of the Shares beneficially owned by the Reporting Person in the open market or in privately negotiated transactions (which may be with the Issuer or with third parties) on such terms and at such times as the Reporting Person may deem advisable.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the footnotes thereto) is incorporated by reference herein.

**(b)**
The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the footnotes thereto) is incorporated by reference herein.

**(c)**
No transactions in the Issuer's Shares were effected during the past 60 days by the Reporting Person.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Not applicable.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Marvin Slosman

**Signature:** /s/ Marvin Slosman

**Name/Title:** Marvin Slosman

**Date:** 04/24/2026